US Patent

US11213498 — Aqueous formulation comprising paracetamol and ibuprofen

Formulation · Assigned to Hyloris Pharmaceuticals SA · Expires 2036-01-14 · 10y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an aqueous formulation of paracetamol and ibuprofen with a pH range of 6.3-7.3.

USPTO Abstract

An aqueous ibuprofen and paracetamol composition has a pH 6.3-7.3. The composition can be used as a medicament, especially for the treatment of pain and/or inflammation. The composition can be formulated for intravenous injection.

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

Patent Metadata

Patent number: US11213498
Jurisdiction: US
Classification: Formulation
Expires: 2036-01-14
Drug substance claim: No
Drug product claim: Yes
Assignee: Hyloris Pharmaceuticals SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.